Osimertinib (AZD9291) and CNS Response in Two Radiotherapy-Naïve Patients with EGFR-Mutant and T790M-Positive Advanced Non-Small Cell Lung Cancer

Authors

Keywords

Epidermal Growth Factor Receptor, Gefitinib, Tyrosine Kinase Inhibitor, Erlotinib, Disease Control Rate

Journal

Volume 36, Issue 8, Pages 683-686

Publisher

Springer Nature

Online

2016-05-13

DOI

10.1007/s40261-016-0411-1

References

View 5 related references

Contact the author

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started